Danaher stock gains ground as latest quote moves above prior report

Danaher stock moved above the level recorded in the latest own report as the company’s third-quarter update remained the central operating reference for investors. At Lang & Schwarz, the stock was quoted at 212.05 EUR on October 29, 2026, at 16:43:10 Berlin time, compared with 207.80 EUR in the own report dated October 28, 2026. That represents a 2.04 percent increase between the two report snapshots and qualifies this second main stock edition. The comparison is separate from a Xetra daily performance measure.

Danaher announced its third-quarter results on October 21, 2026. In the Danaher Investor Relations release, the company reported revenue of USD 6.6 billion, up 8.5 percent year over year. Net earnings from continuing operations were USD 1.2 billion, while adjusted diluted earnings per share reached USD 2.11.

Improving growth excluding respiratory testing

Danaher said non-GAAP core revenue excluding respiratory revenue increased 5.5 percent in the quarter, compared with 3.0 percent for total core revenue. Respiratory testing remained a drag on the headline core figure, making the adjusted underlying trend an important measure for investors assessing demand across the portfolio.

The company also reported operating cash flow of USD 1.9 billion and non-GAAP free cash flow of USD 1.6 billion. Management attributed the stronger performance to improving end markets and execution through the Danaher Business System. These are company-reported measures; adjusted figures exclude specified items and should not be treated as a substitute for GAAP results.

Raised outlook and investor context

For the fourth quarter, Danaher expects core revenue excluding respiratory revenue to increase between 4.0 and 5.0 percent year over year. Respiratory revenue is expected to remain a headwind, with total core revenue growth projected at approximately 3.0 percent.

For the full year, management raised adjusted diluted earnings-per-share guidance to a range of USD 8.57 to USD 8.62 from the previous range of USD 8.45 to USD 8.60. The outlook supports a constructive operating trend, although the continuing respiratory weakness and the company’s reliance on adjusted measures remain relevant considerations.

The real-time quote of Danaher stock provides the latest market reference for the identified instrument.

In the wider US market, investors can follow developments through the S&P 500 market overview.

More news and analyses on Danaher stock are available on the company topic page.